Oxford Bioscience Partners - aVenture Asset Manager Research
Location
Boston, MA, US
Founded
1992
Oxford Bioscience Partners is a global venture capital firm that focuses on investing in the life sciences, technology, energy, and healthcare sectors. The firm typically participates in various stages of funding, including Series A, B, C, D, and beyond, with a notable presence in Series B rounds. Their investments span a wide range of companies worldwide, reflecting their broad industry focus and commitment to fostering innovation across multiple sectors.
Notable portfolio companies include Accelerated Technologies, Adastra Pharmaceuticals, BrainCells, Cambrios Technologies, and CardioFocus. Key decision-makers at Oxford Bioscience Partners bring extensive experience and industry connections to the table, enhancing the firm's ability to support its portfolio companies. The firm prides itself on offering unique value-add services, such as strategic guidance and leveraging their global network to help startups scale effectively.
Oxford Bioscience Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
